Published

Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience of consciousness
Date: 2026-08-20
Source: Europe PMC
DOI: 10.1093/nc/niag050
PubMed: 42626628

Authors

Jaeckel LF Logvinski D Kanana M Müller F Rohner N Becker AM Liechti ME Sterzer P.

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Healthy Volunteers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-07-21 Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind TrialClinicalTrials.gov · 2026-07-17 PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2025-09-18 Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29 Dimensions of consciousness and the psychedelic state.Neuroscience of consciousness · 2018-01-01 Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtClinicalTrials.gov · 2026-07-23